Wilson Karen J

Wilson Karen J is listed in filings as Director at Serina Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 15, 2026, including purchase activity. Recent filings connect the profile to Serina Therapeutics, Inc. (SER), LAVA Therapeutics N.V. (LVTX), and Elicio Therapeutics, Inc. (ELTX). The current snapshot covers public activity from Nov 25, 2024 to Jun 15, 2026. Reported amounts are shown as $8.8K to $19.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.